Identifying Inflammatory Mediators of Clonal Hematopoiesis

识别克隆造血的炎症介质

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT Clonal hematopoiesis (CH) is a common phenomenon defined as the presence of somatic mutations in hematopoietic stem and progenitor cells (HSPCs) and their expansion in the absence of overt hematological disease. CH-mutant mature, myeloid cells are believed to generate an inflammatory microenvironment promoting the fitness advantage of mutant HSPCs. These, in turn, would expand at higher rates and differentiate into more elevated numbers of myeloid cells, thereby establishing a positive feedback loop between inflammatory signaling and clonal expansion. Yet, whether CH-mutant HSPCs can also trigger cell-autonomous inflammatory signaling to provide a selective clonal advantage for themselves remains unknown. CH increases the risk of hematological malignancy, cardiovascular disease, and mortality from solid tumors. Due to these adverse outcomes and the high prevalence of CH in the elderly, there is an unmet need to develop novel therapies. Targeting inflammation specifically in mutant HSPCs —to avoid disruption of general immune responses— may be a potentially effective strategy. My predoctoral research (Aim 1) aims to identify inflammatory mediators of CH-mutant HSPCs and evaluate their potential as therapeutic targets to restore oligoclonal hematopoiesis. To find novel, cell-autonomous inflammatory pathways in CH, I have designed an sgRNA library to target inflammation-associated genes. Using this library for high-throughput CRISPR/Cas9 screening, I have identified both general and genotype-specific inflammatory dependencies of CH-mutant murine HSPCs. In this proposal, Specific Aim 1.1 seeks to validate the negative selection hits, demonstrate that, when present, the hit genes confer a selective advantage to CH-mutant HSPCs versus wild-type counterparts, and delineate the specific role of credential top hits in clonal expansion. In Specific Aim 1.2, I will use small molecule inhibitors targeting the candidate genes —both ex vivo and in mice— to identify gene expression and cytokine profile changes spanning the hematopoietic cell subsets. I will then assess differences between genetic and chemical approaches concerning their efficiency in achieving adequate target inhibition. My postdoctoral research (Aim 2) will focus on the role of inflammation at the nexus of aging and CH by uncovering the transcriptional and epigenetic mechanisms by which age-related inflammation promotes CH and potential malignant transformation to leukemia. Overall, these two projects, which will use human samples to validate the mouse findings, will lead to developing new therapies targeting inflammation to halt or revert CH and mitigate its clinical sequelae. I, the applicant, will conduct this proposal in the laboratory of Dr. Ross Levine at Memorial Sloan Kettering Cancer Center (MSK), one of the world's leading institutions in cancer treatment and research. MSK's rich environment and abundant resources in conjunction with the support of the Gerstner Sloan Kettering Graduate School, guarantee the successful completion of the proposed research and career development plans.
项目总结/摘要 克隆性造血(CH)是一种常见的现象,定义为在造血干细胞中存在体细胞突变。 造血干细胞和祖细胞(HSPC)及其在缺乏明显血液学特征的情况下的扩增 疾病CH-突变的成熟骨髓细胞被认为产生炎症微环境 促进突变体HSPC的适应性优势。反过来,它们将以更高的速度扩张, 转化为更多数量的髓样细胞,从而在炎症和炎症之间建立正反馈回路。 信号传导和克隆扩增。然而,CH-突变的HSPC是否也可以触发细胞自主炎症反应, 为自身提供选择性克隆优势的信号传导仍然未知。CH会增加 血液恶性肿瘤、心血管疾病和实体瘤死亡率。由于这些不利的 然而,由于CH在老年人中的高患病率和预后,开发新疗法的需求尚未得到满足。 特异性靶向突变HSPC中的炎症-以避免破坏一般免疫应答-可以 这是一个潜在的有效策略。我的博士前研究(目标1)旨在确定炎症介质, CH-突变HSPC和评估其作为治疗靶点恢复寡克隆造血的潜力。到 为了在CH中发现新的细胞自主炎症通路,我设计了一个sgRNA文库, 炎症相关基因使用这个文库进行高通量CRISPR/Cas9筛选,我已经鉴定出 CH突变型鼠HSPC的一般和基因型特异性炎症依赖性。在这项提案中, 具体目标1.1旨在验证阴性选择命中,证明当存在时,命中基因 赋予CH-突变HSPCs相对于野生型对应物的选择性优势,并描绘了其特定作用, 在克隆扩张中的最佳点击率。在具体目标1.2中,我将使用小分子抑制剂靶向 候选基因-体外和小鼠-以鉴定基因表达和细胞因子谱变化 跨越造血细胞亚群。然后,我将评估遗传和化学方法之间的差异 关于它们在实现足够的靶抑制方面的效率。我的博士后研究(目标2)将集中在 通过揭示转录和表观遗传的作用, 年龄相关性炎症促进CH和潜在恶性转化的机制, 白血病总的来说,这两个项目将使用人类样本来验证小鼠的发现, 开发针对炎症的新疗法,以停止或逆转CH并减轻其临床后遗症。一世 申请人将在纪念斯隆-凯特琳癌症中心的Ross Levine博士的实验室进行本提案 中心(MSK),世界领先的癌症治疗和研究机构之一。MSK丰富的环境 和丰富的资源,在郭士纳斯隆凯特琳研究生院的支持下, 保证顺利完成拟议的研究和职业发展计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ines Fernandez Maestre其他文献

Ines Fernandez Maestre的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    $ 4.92万
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    $ 4.92万
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    $ 4.92万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 4.92万
  • 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了